The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Novartis; PharmaMar; Roche
Risk assessment after neoadjuvant chemotherapy in luminal breast cancer: A prospectively planned validation of gene expression based and clinical prognostic scores in 428 residual tumor samples from two neoadjuvant clinical trials.
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - AstraZeneca; Celgene; Myriad Genetics; Roche
 
Karsten Weber
Employment - Sividon Diagnostics
Stock and Other Ownership Interests - Sividon Diagnostics
Patents, Royalties, Other Intellectual Property - Sividon Diagnostics
 
Kristin Krappmann
Employment - Sividon Diagnostics
Patents, Royalties, Other Intellectual Property - Sividon Diagnostics (Inst)
 
Jens Bodo Huober
No Relationships to Disclose
 
Frederik Marmé
No Relationships to Disclose
 
Christian Schem
No Relationships to Disclose
 
Knut Engels
No Relationships to Disclose
 
Berit Maria Pfitzner
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Jenny Furlanetto
No Relationships to Disclose
 
Arndt Hartmann
No Relationships to Disclose
 
Silvia Darb-Esfahani
No Relationships to Disclose
 
Volkmar Mueller
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; Hexal; Janssen-Cilag; Medac; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Janssen-Cilag; Pierre Fabre
 
Annette Staebler
No Relationships to Disclose
 
Keyur Mehta
No Relationships to Disclose
 
Gunter Von Minckwitz
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Ralf Kronenwett
Employment - Sividon Diagnostics
Leadership - Sividon Diagnostics
Stock and Other Ownership Interests - Sividon Diagnostics
Patents, Royalties, Other Intellectual Property - Sividon Diagnostics
 
Sibylle Loibl
No Relationships to Disclose